Goldman Sachs’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Buy |
|
|||||
|
2025
Q1 | $213K | Sell |
|
|||||
|
2024
Q4 | $531K | Buy |
|
|||||
|
2024
Q3 | $423K | Buy |
|
|||||
|
2024
Q2 | $343K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $214K | Sell |
|
|||||
|
2023
Q3 | $27.7K | Sell |
|
|||||
|
2023
Q2 | $125K | Sell |
|
|||||
|
2023
Q1 | $1.51M | Buy |
|
|||||
|
2022
Q4 | $2.71M | Sell |
|
|||||
|
2022
Q3 | $3.92M | Buy |
|
|||||
|
2022
Q2 | $2.58M | Buy |
|
|||||
|
2022
Q1 | $3.35M | Sell |
|
|||||
|
2021
Q4 | $8.61M | Sell |
|
|||||
|
2021
Q3 | $12.6M | Buy |
|
|||||
|
2021
Q2 | $12.1M | Buy |
|
|||||
|
2021
Q1 | $2.37M | Buy |
|
|||||
|
2020
Q4 | $1.65M | Sell |
|
|||||
|
2020
Q3 | $6.4M | Buy |
|
|||||
|
2020
Q2 | $14.4M | Buy |
|
|||||
|
2020
Q1 | $3.58M | Buy |
|
|||||
|
2019
Q4 | $603K | Buy |
|
|||||
|
2019
Q3 | $209K | Sell |
|
|||||
|
2019
Q2 | $324K | Sell |
|
|||||
|
2019
Q1 | $442K | Sell |
|
|||||
|
2018
Q4 | $839K | Buy |
|
|||||
|
2018
Q3 | $892K | Buy |
|
|||||
|
2018
Q2 | $588K | Buy |
|
|||||
|
2018
Q1 | $650K | Buy |
|
|||||
|
2017
Q4 | $368K | Sell |
|
|||||
|
2017
Q3 | $583K | Sell |
|
|||||
|
2017
Q2 | $1.46M | Buy |
|
|||||
|
2017
Q1 | $522K | Sell |
|
|||||
|
2016
Q4 | $776K | Buy |
|
|||||
|
2016
Q3 | $776K | Buy |
|
|||||
|
2016
Q2 | $442K | Buy |
|
|||||
|
2016
Q1 | $321K | Buy |
|
|||||
|
2015
Q4 | $44K | Sell |
|
|||||
|
2015
Q3 | $287K | Sell |
|
|||||
|
2015
Q2 | $1.22M | Buy |
|
|||||
|
2015
Q1 | $1.17M | Sell |
|
|||||
|
2014
Q4 | $2.52M | Sell |
|
|||||
|
2014
Q3 | $3.62M | Sell |
|
|||||
|
2014
Q2 | $5.14M | Buy |
|
|||||
|
2014
Q1 | $673K | Sell |
|
|||||
|
2013
Q4 | $3.01M | Buy |
|